speb/financial-data huggingface dataset:
Financial ratios for BGDE — quarterly report dated 2025-09-30
Total revenue: 13174706
Gross profit: 8563298
Operating income: 2780010
Net income: 327659
Capital expenditures: 0
Operating cash flow: -844509
Depreciation & amortization: 1683335
Net tangible assets: -9403538
Owner earnings: 2010994
Return on net tangible assets (%): -21.385504051772855
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.4
P/E ratio: 35.386268040859555
Shares outstanding: 5521252
Book value: -9403538
Market cap (USD): 46378516.800000004
Debt to equity: -2.900632293930221
Current ratio: 0.3531041301715921
Quick ratio: 0.3531041301715921
Effective tax rate (%): 22.257495841904586
Interest coverage ratio: 3.2024739598332874
COGS to revenue (%): 35.001980309845244
SG&A to revenue (%): 33.68971573255601
Free cash flow (dilution-adjusted): 540507
Buyback yield (%): 0
Retained earnings: -236802803
Receivables turnover: 0.9577195371149136
Capitalized R&D asset: 0
FCF margin (%): 4.102611473834786
Revenue growth (%): 38.19839606561628
Rule of 40 score: 42.301007539451064
Financial ratios for BGDE — annual report dated 2025-12-31
Total revenue: 39754085
Gross profit: 17343251
Operating income: -19883217
Net income: -23656569
Capital expenditures: 39260
Operating cash flow: -6899676
Depreciation & amortization: 6915179
Net tangible assets: -3117791
Owner earnings: -16780650
Buffett classification: The Gruesome
Stock price: 4.21
Shares outstanding: 5521252
Book value: -3117791
Market cap (USD): 23244470.919999998
Debt to equity: -9.135416389360287
Current ratio: 0.4672668226734425
Quick ratio: 0.4672668226734425
Interest coverage ratio: -5.906165092191667
COGS to revenue (%): 56.37366323486002
SG&A to revenue (%): 79.55327106635708
Free cash flow (dilution-adjusted): -16024205
Buyback yield (%): 0
Retained earnings: -252454735
Receivables turnover: 4.122831470886519
Capitalized R&D asset: 0
FCF margin (%): -40.308323031457014
Revenue growth (%): -32.92162127389422
Rule of 40 score: -73.22994430535124
Financial ratios for BGDE — quarterly report dated 2025-12-31
Total revenue: 3231823
Gross profit: -1077607
Operating income: -14744274
Net income: -15651932
Capital expenditures: 39260
Operating cash flow: -3466183
Depreciation & amortization: 1610414
Net tangible assets: -3117791
Owner earnings: -14080778
Buffett classification: The Gruesome
Stock price: 4.21
Shares outstanding: 5521252
Book value: -3117791
Market cap (USD): 23244470.919999998
Debt to equity: -9.135416389360287
Current ratio: 0.4672668226734425
Quick ratio: 0.4672668226734425
Interest coverage ratio: -16.636961260883105
COGS to revenue (%): 133.34362680134402
SG&A to revenue (%): 383.8289720693243
Free cash flow (dilution-adjusted): -10842331
Buyback yield (%): 0
Retained earnings: -252454735
Receivables turnover: 0.3351671047826879
Capitalized R&D asset: 0
FCF margin (%): -335.48653499897733
Revenue growth (%): -75.46948675742745
Rule of 40 score: -410.95602175640477
Financial ratios for BMRA — annual report dated 2021-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.2
Shares outstanding: 3090269
Market cap (USD): 90235854.8
Buyback yield (%): 0.1838725863103366
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMRA — annual report dated 2022-05-31
Total revenue: 18871000
Gross profit: 2977000
Operating income: -4534000
Net income: -4531000
Capital expenditures: 57000
Operating cash flow: -479000
Depreciation & amortization: 595000
Net tangible assets: 8155000
Owner earnings: -3993000
Return on net tangible assets (%): -48.96382587369712
Buffett classification: The Gruesome
Stock price: 28
Shares outstanding: 3090269
Book value: 8325000
P/B ratio: 10.393697537537538
Market cap (USD): 86527532
Debt to equity: 0.16564564564564566
Current ratio: 4.687717553455992
Quick ratio: 3.486325211337643
COGS to revenue (%): 84.22447141115998
R&D to revenue (%): 9.602034868316464
SG&A to revenue (%): 30.199777436277884
Free cash flow (dilution-adjusted): -1909000
Buyback yield (%): 0.0982346289502398
Retained earnings: -35077000
Inventory turnover: 6.578642384105961
Receivables turnover: 24.38113695090439
Capitalized R&D asset: 1812000
ROCI (R&D-adjusted, %): -29.762863534675617
FCF margin (%): -10.11605108367336
Rule of 40 score: -10.11605108367336
Financial ratios for BMRA — annual report dated 2023-05-31
Total revenue: 5339000
Gross profit: 446000
Operating income: -7223000
Net income: -7140000
Capital expenditures: 64000
Operating cash flow: -5474000
Depreciation & amortization: 351000
Net tangible assets: 11559000
Owner earnings: -6853000
Return on net tangible assets (%): -59.28713556536033
Buffett classification: The Gruesome
Stock price: 10.96
Shares outstanding: 3090269
Book value: 11724000
P/B ratio: 2.888890160354828
Market cap (USD): 33869348.24
Debt to equity: 0.0922893210508359
Current ratio: 6.5794344473007715
Quick ratio: 5.5223650385604115
COGS to revenue (%): 91.64637572579136
R&D to revenue (%): 29.668477242929388
SG&A to revenue (%): 113.97265405506649
Free cash flow (dilution-adjusted): -6737000
Buyback yield (%): 2.08152809733548
Retained earnings: -42217000
Inventory turnover: 2.379863813229572
Receivables turnover: 7.394736842105263
Capitalized R&D asset: 2798040
ROCI (R&D-adjusted, %): -44.23454828627873
Rosenberg metric: -1.3967991169977925
FCF margin (%): -126.18467877879753
Revenue growth (%): -71.7079116104075
Rule of 40 score: -197.89259038920505
Financial ratios for BMRA — annual report dated 2024-05-31
Total revenue: 5415000
Gross profit: 611000
Operating income: -6367000
Net income: -5978000
Capital expenditures: 51000
Operating cash flow: -5361000
Depreciation & amortization: 374000
Net tangible assets: 6379000
Owner earnings: -5655000
Return on net tangible assets (%): -88.65025866123217
Buffett classification: The Gruesome
Stock price: 4.64
Shares outstanding: 3090269
Book value: 6591000
P/B ratio: 2.1755193688362917
Market cap (USD): 14338848.159999998
Debt to equity: 0.11910180549233804
Current ratio: 3.5077132486388383
Quick ratio: 2.42967332123412
COGS to revenue (%): 88.71652816251154
R&D to revenue (%): 27.534626038781163
SG&A to revenue (%): 101.32963988919667
Free cash flow (dilution-adjusted): -6313000
Buyback yield (%): 0
Retained earnings: -48195000
Inventory turnover: 2.021885521885522
Receivables turnover: 5.71805702217529
Capitalized R&D asset: 3150240
ROCI (R&D-adjusted, %): -63.77300926252716
Rosenberg metric: 0.10416666666666667
FCF margin (%): -116.58356417359188
Revenue growth (%): 1.4234875444839856
Rule of 40 score: -115.16007662910789
Financial ratios for BMRA — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.52
Shares outstanding: 3090269
Market cap (USD): 10877746.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMRA — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.12
Shares outstanding: 3090269
Market cap (USD): 9641639.280000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMRA — quarterly report dated 2025-02-28
Total revenue: 1119000
Gross profit: 19000
Operating income: -1210000
Net income: -1163000
Capital expenditures: 0
Operating cash flow: -1045000
Depreciation & amortization: 99000
Net tangible assets: 5300000
Owner earnings: -1064000
Return on net tangible assets (%): -20.075471698113205
Buffett classification: The Gruesome
Stock price: 5.84
Shares outstanding: 3090269
Book value: 5534000
P/B ratio: 3.2611440115648715
Market cap (USD): 18047170.96
Debt to equity: 0.09812070834839176
Current ratio: 3.7622801697998787
Quick ratio: 2.758641600970285
COGS to revenue (%): 98.30205540661304
R&D to revenue (%): 19.3923145665773
SG&A to revenue (%): 90.437890974084
Free cash flow (dilution-adjusted): -1169000
Buyback yield (%): 0
Retained earnings: -51624000
Inventory turnover: 0.6646525679758308
Receivables turnover: 0.8824921135646687
Capitalized R&D asset: 217000
ROCI (R&D-adjusted, %): -17.922835352175863
FCF margin (%): -104.46827524575515
Rule of 40 score: -104.46827524575515
Financial ratios for BMRA — quarterly report dated 2025-05-31
Total revenue: 749000
Gross profit: -244000
Operating income: -1564000
Net income: -1544000
Capital expenditures: 0
Operating cash flow: -661000
Depreciation & amortization: 104000
Net tangible assets: 3877000
Owner earnings: -1440000
Return on net tangible assets (%): -37.142120196027854
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 3090269
Book value: 4105000
P/B ratio: 2.296058574908648
Market cap (USD): 9425320.45
Debt to equity: 0.11157125456760049
Current ratio: 2.8017241379310347
Quick ratio: 1.9454022988505748
COGS to revenue (%): 132.57676902536716
R&D to revenue (%): 33.64485981308411
SG&A to revenue (%): 142.59012016021362
Free cash flow (dilution-adjusted): -769000
Buyback yield (%): 0
Retained earnings: -53168000
Inventory turnover: 0.6664429530201342
Receivables turnover: 1.024623803009576
Capitalized R&D asset: 397390
ROCI (R&D-adjusted, %): -31.903713795078932
Rosenberg metric: -1.2119815668202765
FCF margin (%): -102.6702269692924
Revenue growth (%): -33.065236818588026
Rule of 40 score: -135.73546378788043
Financial ratios for BMRA — annual report dated 2025-05-31
Total revenue: 5311000
Gross profit: 498000
Operating income: -5137000
Net income: -4973000
Capital expenditures: 0
Operating cash flow: -3841000
Depreciation & amortization: 400000
Net tangible assets: 3877000
Owner earnings: -4573000
Return on net tangible assets (%): -117.95202476141347
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 3090269
Book value: 4105000
P/B ratio: 2.296058574908648
Market cap (USD): 9425320.45
Debt to equity: 0.11157125456760049
Current ratio: 2.8017241379310347
Quick ratio: 1.9454022988505748
COGS to revenue (%): 90.62323479570702
R&D to revenue (%): 19.261909244963284
SG&A to revenue (%): 86.83863679156467
Free cash flow (dilution-adjusted): -4338000
Buyback yield (%): 0
Retained earnings: -53168000
Inventory turnover: 3.2302013422818794
Receivables turnover: 7.265389876880985
Capitalized R&D asset: 2544690
ROCI (R&D-adjusted, %): -81.18891386122918
Rosenberg metric: -0.07578806170355466
FCF margin (%): -81.67953304462436
Revenue growth (%): -1.920590951061865
Rule of 40 score: -83.60012399568623
Financial ratios for BMRA — quarterly report dated 2025-08-31
Total revenue: 1380000
Gross profit: 424000
Operating income: -1118000
Net income: 2000
Capital expenditures: 0
Operating cash flow: -268000
Depreciation & amortization: 102000
Net tangible assets: 4932000
Owner earnings: 104000
Return on net tangible assets (%): 2.10867802108678
Buffett classification: The Gruesome
Stock price: 3.13
P/E ratio: 1209.0677462499998
Shares outstanding: 3090269
Book value: 5155000
P/B ratio: 1.8763417982541222
Market cap (USD): 9672541.969999999
Debt to equity: 0.07235693501454898
Current ratio: 3.4843473124630835
Quick ratio: 2.614294152392203
Effective tax rate (%): 60
COGS to revenue (%): 69.27536231884058
R&D to revenue (%): 15.36231884057971
SG&A to revenue (%): 96.37681159420289
Free cash flow (dilution-adjusted): -401000
Buyback yield (%): 0
Retained earnings: -53166000
Inventory turnover: 0.6490156143923965
Receivables turnover: 1.1452282157676348
Capitalized R&D asset: 452450
ROCI (R&D-adjusted, %): -20.18366601644265
Rosenberg metric: 2.6507936507936507
FCF margin (%): -29.057971014492757
Revenue growth (%): 84.2456608811749
Rule of 40 score: 55.18768986668214
Financial ratios for BMRA — quarterly report dated 2025-11-30
Total revenue: 1210000
Gross profit: 51000
Operating income: -1373000
Net income: -1320000
Capital expenditures: 0
Operating cash flow: -991000
Depreciation & amortization: 103000
Net tangible assets: 4216000
Owner earnings: -1217000
Return on net tangible assets (%): -28.866223908918403
Buffett classification: The Gruesome
Stock price: 2.37
Shares outstanding: 3090269
Book value: 4435000
P/B ratio: 1.651395158962796
Market cap (USD): 7323937.53
Debt to equity: 0.06403607666290868
Current ratio: 3.2464040025015635
Quick ratio: 2.293308317698562
COGS to revenue (%): 95.78512396694215
R&D to revenue (%): 15.950413223140497
SG&A to revenue (%): 101.73553719008264
Free cash flow (dilution-adjusted): -1108000
Buyback yield (%): 0
Retained earnings: -54486000
Inventory turnover: 0.760498687664042
Receivables turnover: 1.2777191129883845
Capitalized R&D asset: 418200
ROCI (R&D-adjusted, %): -28.826341383005026
Rosenberg metric: -1.759433962264151
FCF margin (%): -91.5702479338843
Revenue growth (%): -12.318840579710146
Rule of 40 score: -103.88908851359444
Financial ratios for CEPO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -192548
Net income: 993400
Capital expenditures: 0
Operating cash flow: 52579
Net tangible assets: 201381845
Owner earnings: 993400
Return on net tangible assets (%): 0.4932917364025541
Buffett classification: The Gruesome
Stock price: 10.24
P/E ratio: 52.82866921683108
Shares outstanding: 20500000
Book value: 201381845
P/B ratio: 1.0423978387922703
Market cap (USD): 209920000
Debt to equity: 0
Current ratio: 2.354797883744251
Quick ratio: 2.354797883744251
Free cash flow (dilution-adjusted): 52579
Buyback yield (%): 0
Retained earnings: -2804653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09561338560583751
Rule of 40 score: 0
Financial ratios for CEPO — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -174401
Net income: 1955328
Capital expenditures: 0
Operating cash flow: -1
Net tangible assets: 203337173
Owner earnings: 1955328
Return on net tangible assets (%): 0.9616185624848832
Buffett classification: The Gruesome
Stock price: 11.9
P/E ratio: 82.73058756182327
Shares outstanding: 20500000
Book value: 203337173
P/B ratio: 1.1997314431041097
Market cap (USD): 243950000
Debt to equity: 0.0011991953876529994
Current ratio: 0.7720414563556028
Quick ratio: 0.7720414563556028
Free cash flow (dilution-adjusted): -1
Buyback yield (%): 0
Retained earnings: -2979054
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.08576936397163346
Rule of 40 score: 0
Financial ratios for CEPO — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -388159
Net income: 1191376
Capital expenditures: 0
Operating cash flow: 0
Net tangible assets: 204528549
Owner earnings: 1191376
Return on net tangible assets (%): 0.5824986320124923
Buffett classification: The Gruesome
Stock price: 10.46
P/E ratio: 51.793384900475935
Shares outstanding: 20500000
Book value: 204528549
P/B ratio: 1.0484110949224992
Market cap (USD): 214430000.00000003
Debt to equity: 0.0016147427907484936
Current ratio: 0.35882821192134395
Quick ratio: 0.35882821192134395
Free cash flow (dilution-adjusted): 0
Buyback yield (%): 0
Retained earnings: -3937012
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.18925505923626454
Rule of 40 score: 0
Financial ratios for CEPO — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -218451
Net income: -10797046
Capital expenditures: 0
Operating cash flow: 0
Net tangible assets: 193731503
Owner earnings: -10797046
Return on net tangible assets (%): -5.573200967733162
Buffett classification: The Gruesome
Stock price: 10.41
Shares outstanding: 20500000
Book value: 193731503
P/B ratio: 1.1015503245231106
Market cap (USD): 213405000
Debt to equity: 0.0025060663468862883
Current ratio: 0.2645330894388177
Quick ratio: 0.2645330894388177
Free cash flow (dilution-adjusted): 0
Buyback yield (%): 0
Retained earnings: -16782528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.10556841633994048
Rule of 40 score: 0
Financial ratios for CEPO — annual report dated 2025-12-31
Total revenue: 0
Operating income: -973559
Net income: -6656942
Capital expenditures: 0
Operating cash flow: 52578
Net tangible assets: 193731503
Owner earnings: -6656942
Return on net tangible assets (%): -3.436169077777712
Buffett classification: The Gruesome
Stock price: 10.41
Shares outstanding: 20500000
Book value: 193731503
P/B ratio: 1.1015503245231106
Market cap (USD): 213405000
Debt to equity: 0.0025060663468862883
Current ratio: 0.2645330894388177
Quick ratio: 0.2645330894388177
Free cash flow (dilution-adjusted): 52578
Buyback yield (%): 0
Retained earnings: -16782528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.47048116897380243
Rule of 40 score: 0
Financial ratios for CM.TO — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 48.65853658536586
Shares outstanding: 912800674
Market cap (USD): 44415544990.97562
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CM.TO — annual report dated 2022-10-31
Total revenue: 16002941176.470587
Net income: 4590441176.470588
Capital expenditures: 815441176.4705882
Operating cash flow: 16702205882.35294
Depreciation & amortization: 769852941.1764705
Net tangible assets: 31059558823.52941
Owner earnings: 4544852941.17647
Return on net tangible assets (%): 14.632702824270257
Buffett classification: The Gruesome
Stock price: 38.04411764705882
P/E ratio: 7.565001901771584
Shares outstanding: 912800674
Book value: 37045588235.29419
P/B ratio: 0.9374043680830435
Market cap (USD): 34726696229.97058
Debt to equity: 3.7206542018974953
Effective tax rate (%): 21.698231531418536
COGS to revenue (%): 0
SG&A to revenue (%): 34.41922440727807
Free cash flow (dilution-adjusted): 15869117647.05882
Buyback yield (%): 1.9776275328191066
Retained earnings: 21193382352.941174
Receivables turnover: 1.1015842486207421
Capitalized R&D asset: 0
FCF margin (%): 99.16375666237823
Rule of 40 score: 99.16375666237823
Financial ratios for CM.TO — annual report dated 2023-10-31
Total revenue: 16883333333.333334
Net income: 3651449275.362319
Capital expenditures: 734782608.6956522
Operating cash flow: 8807246376.811594
Depreciation & amortization: 828260869.5652175
Net tangible assets: 32437681159.42029
Owner earnings: 3744927536.231884
Return on net tangible assets (%): 11.544991511035652
Buffett classification: The Gruesome
Stock price: 31.55072463768116
P/E ratio: 7.8871485108077
Shares outstanding: 912800674
Book value: 38523913043.47827
P/B ratio: 0.7475752185911252
Market cap (USD): 28799522714.463768
Debt to equity: 3.6585595244813116
Effective tax rate (%): 27.735551412591423
COGS to revenue (%): 0
SG&A to revenue (%): 33.70960127044079
Free cash flow (dilution-adjusted): 8063043478.260871
Buyback yield (%): 0
Retained earnings: 21994202898.550728
Receivables turnover: 1.672817346352671
Capitalized R&D asset: 0
FCF margin (%): 47.75741448130822
Revenue growth (%): 5.5014396863321835
Rule of 40 score: 53.2588541676404
Financial ratios for CM.TO — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 58.74820143884892
Shares outstanding: 912800674
Market cap (USD): 53625397869.66907
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CM.TO — annual report dated 2024-10-31
Total revenue: 18364028776.97842
Net income: 5146762589.928058
Capital expenditures: 783453237.410072
Operating cash flow: 7976978417.266188
Depreciation & amortization: 841726618.705036
Net tangible assets: 36303597122.30216
Owner earnings: 5205035971.2230215
Return on net tangible assets (%): 14.337521303158809
Buffett classification: The Gruesome
Stock price: 58.74820143884892
P/E ratio: 10.41924839793682
Shares outstanding: 912800674
Book value: 42451079136.690674
P/B ratio: 1.2632281430820065
Market cap (USD): 53625397869.66907
Debt to equity: 3.5333604487603143
Effective tax rate (%): 21.950687322714376
COGS to revenue (%): 0
SG&A to revenue (%): 33.71072631826373
Free cash flow (dilution-adjusted): 7182014388.489209
Buyback yield (%): 1.8755206220154055
Retained earnings: 24079856115.107914
Receivables turnover: 1.6872232136955518
Capitalized R&D asset: 0
FCF margin (%): 39.10914361827157
Revenue growth (%): 8.770160574403276
Rule of 40 score: 47.879304192674844
Financial ratios for CM.TO — quarterly report dated 2025-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 59.81379310344828
Shares outstanding: 912800674
Market cap (USD): 54598070659.32414
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CM.TO — quarterly report dated 2025-04-30
Total revenue: 5062318840.579711
Net income: 1454347826.0869567
Capital expenditures: 178260869.5652174
Operating cash flow: 662318840.5797102
Depreciation & amortization: 203623188.40579712
Net tangible assets: 38734057971.014496
Owner earnings: 1479710144.9275365
Return on net tangible assets (%): 3.8201784745477343
Buffett classification: The Gruesome
Stock price: 60.40579710144928
P/E ratio: 9.47820929056303
Shares outstanding: 912800674
Book value: 44888405797.10144
P/B ratio: 1.2283450777231786
Market cap (USD): 55138452307.71015
Debt to equity: 3.482646175701418
Effective tax rate (%): 22.74826789838337
COGS to revenue (%): 0
SG&A to revenue (%): 33.595762954480385
Free cash flow (dilution-adjusted): 479710144.9275363
Buyback yield (%): 0.6439652346180658
Retained earnings: 25350724637.68116
Capitalized R&D asset: 0
FCF margin (%): 9.476095047237331
Rule of 40 score: 9.476095047237331
Financial ratios for CM.TO — quarterly report dated 2025-07-31
Total revenue: 5235507246.376812
Net income: 1518840579.710145
Capital expenditures: 204347826.08695653
Operating cash flow: 4247101449.2753625
Depreciation & amortization: 207971014.49275362
Net tangible assets: 39381884057.971016
Owner earnings: 1522463768.115942
Return on net tangible assets (%): 3.865898761661177
Buffett classification: The Gruesome
Stock price: 69.5
P/E ratio: 21.33724412462588
Shares outstanding: 912800674
Book value: 45562318840.57971
P/B ratio: 1.392370898965265
Market cap (USD): 63439646843
Debt to equity: 3.5559354920796493
Effective tax rate (%): 22.912835601324016
COGS to revenue (%): 0
SG&A to revenue (%): 34.24221453287197
Free cash flow (dilution-adjusted): 4040579710.1449275
Buyback yield (%): 0.9549187796528847
Retained earnings: 25836956521.739132
Capitalized R&D asset: 0
FCF margin (%): 77.17647058823529
Revenue growth (%): 3.421127970226158
Rule of 40 score: 80.59759855846144
Financial ratios for CM.TO — annual report dated 2025-10-31
Total revenue: 20724285714.285717
Net income: 6038571428.571429
Capital expenditures: 792142857.1428572
Operating cash flow: 9884285714.285715
Depreciation & amortization: 841428571.4285715
Net tangible assets: 39828571428.571434
Owner earnings: 6087857142.857143
Return on net tangible assets (%): 15.285150645624102
Buffett classification: The Gruesome
Stock price: 81.09285714285716
P/E ratio: 12.258133489380176
Shares outstanding: 912800674
Book value: 46009285714.285645
P/B ratio: 1.6088407700187877
Market cap (USD): 74021614656.58572
Debt to equity: 3.5051930510921765
Effective tax rate (%): 22.716884541548584
COGS to revenue (%): 0
SG&A to revenue (%): 33.30805817881023
Free cash flow (dilution-adjusted): 9077857142.857143
Buyback yield (%): 2.973069820111642
Retained earnings: 26050714285.714287
Receivables turnover: 1.7156880137188812
Capitalized R&D asset: 0
FCF margin (%): 43.802991659199
Revenue growth (%): 12.852609664095988
Rule of 40 score: 56.65560132329499
Financial ratios for CM.TO — quarterly report dated 2025-10-31
Total revenue: 5392857142.857143
Net income: 1557142857.1428573
Capital expenditures: 277142857.14285713
Operating cash flow: -3065714285.714286
Depreciation & amortization: 231428571.42857143
Net tangible assets: 39828571428.571434
Owner earnings: 1511428571.4285717
Return on net tangible assets (%): 3.7948350071736012
Buffett classification: The Gruesome
Stock price: 81.09285714285716
P/E ratio: 16.339117464127643
Shares outstanding: 912800674
Book value: 46009285714.285645
P/B ratio: 1.6088407700187877
Market cap (USD): 74021614656.58572
Debt to equity: 3.5051930510921765
Effective tax rate (%): 21.91977077363897
COGS to revenue (%): 0
SG&A to revenue (%): 32.82119205298013
Free cash flow (dilution-adjusted): -3349285714.285714
Buyback yield (%): 1.1019947207294691
Retained earnings: 26050714285.714287
Receivables turnover: 0.4464549701377802
Capitalized R&D asset: 0
FCF margin (%): -62.10596026490065
Revenue growth (%): 3.0054374691052916
Rule of 40 score: -59.100522795795364
Financial ratios for CM.TO — quarterly report dated 2026-01-31
Total revenue: 6163703703.703703
Net income: 2296296296.296296
Capital expenditures: 182222222.2222222
Operating cash flow: -1592592592.5925925
Depreciation & amortization: 222962962.96296296
Net tangible assets: 42303703703.7037
Owner earnings: 2337037037.037037
Return on net tangible assets (%): 5.524426545263527
Buffett classification: The Gruesome
Stock price: 91.83703703703704
P/E ratio: 12.279695732360844
Shares outstanding: 912800674
Book value: 48601481481.48157
P/B ratio: 1.7248220990446839
Market cap (USD): 83828909305.57037
Debt to equity: 3.356596354325422
Effective tax rate (%): 11.453870322764924
COGS to revenue (%): 0
SG&A to revenue (%): 32.82057445018628
Free cash flow (dilution-adjusted): -1783703703.7037036
Buyback yield (%): 0.9074921134518327
Retained earnings: 27845925925.925922
Capitalized R&D asset: 0
FCF margin (%): -28.93882946761207
Revenue growth (%): 14.293843512386534
Rule of 40 score: -14.644985955225536
Financial ratios for CPER.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -48933.82352941176
Operating income: -3186720.588235294
Net income: -3093717.647058823
Capital expenditures: 26882.35294117647
Operating cash flow: -2496183.088235294
Depreciation & amortization: 48933.82352941176
Net tangible assets: 5609576.470588235
Owner earnings: -3071666.176470588
Return on net tangible assets (%): -54.757541724865455
Buffett classification: The Gruesome
Stock price: 0.13235294117647056
Shares outstanding: 118957146
Book value: 5609576.470588235
P/B ratio: 2.806687497640589
Market cap (USD): 15744328.14705882
Debt to equity: 0.01581394946457109
Current ratio: 26.298130010207924
Quick ratio: 26.298130010207924
Interest coverage ratio: -241.3913334075972
Free cash flow (dilution-adjusted): -2969425
Buyback yield (%): 0
Retained earnings: -6550384.558823529
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.24347558864401
Rule of 40 score: 0
Financial ratios for CPER.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -56465.15151515151
Operating income: -2240631.818181818
Net income: -2068446.212121212
Capital expenditures: 30456.060606060604
Operating cash flow: -1964573.4848484849
Depreciation & amortization: 56465.15151515151
Net tangible assets: 4732753.787878788
Owner earnings: -2042437.1212121209
Return on net tangible assets (%): -43.155363933003954
Buffett classification: The Gruesome
Stock price: 0.0909090909090909
Shares outstanding: 118957146
Book value: 4732753.787878788
P/B ratio: 2.284988081927444
Market cap (USD): 10814285.999999998
Debt to equity: 0.01128099071029023
Current ratio: 18.986779235369927
Quick ratio: 18.986779235369927
Interest coverage ratio: -244.99950298210737
Free cash flow (dilution-adjusted): -2006935.606060606
Buyback yield (%): 0
Retained earnings: -8817327.272727272
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -47.24139522796473
Rule of 40 score: 0
Financial ratios for CPER.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 118957146
Market cap (USD): 7049312.355555555
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPER.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -52964.33566433567
Operating income: -2525947.5524475523
Net income: -2407123.7762237764
Capital expenditures: 0
Operating cash flow: -1974366.4335664336
Depreciation & amortization: 52964.33566433567
Net tangible assets: 2550345.4545454546
Owner earnings: -2354159.4405594408
Return on net tangible assets (%): -92.30747294895468
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 118957146
Book value: 2550345.4545454546
P/B ratio: 4.5665006413501095
Market cap (USD): 11646154.153846156
Debt to equity: 0.0025947396677921597
Current ratio: 10.017710211771425
Quick ratio: 10.017710211771425
Interest coverage ratio: -678.5844448619199
Free cash flow (dilution-adjusted): -2367995.804195804
Buyback yield (%): 0
Retained earnings: -10546195.104895106
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -97.64285326181714
Rule of 40 score: 0
Financial ratios for CPER.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -16777.622377622378
Operating income: -966457.3426573427
Net income: -955887.4125874126
Capital expenditures: 0
Operating cash flow: -568231.4685314685
Depreciation & amortization: 16777.622377622378
Net tangible assets: 2550345.4545454546
Owner earnings: -939109.7902097902
Return on net tangible assets (%): -36.822846431883356
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 118957146
Book value: 2550345.4545454546
P/B ratio: 4.5665006413501095
Market cap (USD): 11646154.153846156
Debt to equity: 0.0025947396677921597
Current ratio: 10.017710211771425
Quick ratio: 10.017710211771425
Free cash flow (dilution-adjusted): -864198.6013986014
Buyback yield (%): 0
Retained earnings: -10546195.104895106
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -37.35930795612038
Rule of 40 score: 0
Financial ratios for CPER.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -8188.111888111888
Operating income: -434771.32867132867
Net income: -423597.2027972028
Capital expenditures: 0
Operating cash flow: -500643.3566433567
Depreciation & amortization: 8188.111888111888
Net tangible assets: 2126748.2517482517
Owner earnings: -415409.09090909094
Return on net tangible assets (%): -19.53259350595972
Buffett classification: The Gruesome
Stock price: 0.06293706293706294
Shares outstanding: 118957146
Book value: 2126748.251748252
P/B ratio: 3.5203101159062884
Market cap (USD): 7486813.384615385
Debt to equity: 0.022852774352651047
Current ratio: 12.72305956982237
Quick ratio: 12.72305956982237
Interest coverage ratio: -695.4395973154362
Free cash flow (dilution-adjusted): -500643.3566433567
Buyback yield (%): 0
Retained earnings: -10969792.307692308
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.922115325458346
Rule of 40 score: 0
Financial ratios for CPER.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -9228.467153284671
Operating income: -422189.7810218978
Net income: -413232.84671532846
Capital expenditures: 0
Operating cash flow: -424950.3649635036
Depreciation & amortization: 9228.467153284671
Net tangible assets: 2038628.4671532845
Owner earnings: -404004.37956204376
Return on net tangible assets (%): -19.817459928154072
Buffett classification: The Gruesome
Stock price: 0.0656934306569343
Shares outstanding: 118957146
Book value: 2038628.4671532847
P/B ratio: 3.8333139891890955
Market cap (USD): 7814703.021897809
Debt to equity: 0.021811214853552963
Current ratio: 28.223070477609163
Quick ratio: 28.223070477609163
Interest coverage ratio: -345.3134328358209
Free cash flow (dilution-adjusted): -424950.3649635036
Buyback yield (%): 0
Retained earnings: -11863454.01459854
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.015454533185544
Rule of 40 score: 0
Financial ratios for CPER.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -9754.676258992806
Operating income: -739907.1942446043
Net income: -735871.9424460432
Capital expenditures: 25956.115107913673
Operating cash flow: -681964.0287769785
Depreciation & amortization: 9754.676258992806
Net tangible assets: 2944124.460431655
Owner earnings: -752073.3812949641
Return on net tangible assets (%): -25.54489089719727
Buffett classification: The Gruesome
Stock price: 0.07194244604316548
Shares outstanding: 118957146
Book value: 2944124.460431655
P/B ratio: 2.906829576185516
Market cap (USD): 8558068.057553958
Debt to equity: 0.012754094058328096
Current ratio: 16.97893618861795
Quick ratio: 16.97893618861795
Interest coverage ratio: -579.4202816901409
Free cash flow (dilution-adjusted): -746286.3309352518
Buyback yield (%): 0
Retained earnings: -12428628.776978418
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.54037691836712
Rule of 40 score: 0
Financial ratios for CPER.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -37989.781021897805
Operating income: -2802681.751824817
Net income: -2788902.919708029
Capital expenditures: 27233.576642335764
Operating cash flow: -2775042.335766423
Depreciation & amortization: 37989.781021897805
Net tangible assets: 1785086.8613138685
Owner earnings: -2778146.715328467
Return on net tangible assets (%): -155.6308981672568
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 118957146
Book value: 1785086.8613138685
P/B ratio: 3.4049336657440454
Market cap (USD): 6078102.3503649635
Debt to equity: 0.017716940311232273
Current ratio: 6.093837329916408
Quick ratio: 6.093837329916408
Interest coverage ratio: -675.8799507129027
Free cash flow (dilution-adjusted): -2841202.189781022
Buyback yield (%): 0
Retained earnings: -13796975.18248175
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -153.1115791689961
Rule of 40 score: 0
Financial ratios for CPER.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -10317.518248175182
Operating income: -1175970.802919708
Net income: -1186906.5693430656
Capital expenditures: 898.5401459854014
Operating cash flow: -1135602.9197080291
Depreciation & amortization: 10317.518248175182
Net tangible assets: 1785086.8613138685
Owner earnings: -1177487.5912408757
Return on net tangible assets (%): -65.9624815329275
Buffett classification: The Gruesome
Stock price: 0.051094890510948905
Shares outstanding: 118957146
Book value: 1785086.8613138685
P/B ratio: 3.4049336657440454
Market cap (USD): 6078102.3503649635
Debt to equity: 0.017716940311232273
Current ratio: 6.093837329916408
Quick ratio: 6.093837329916408
Interest coverage ratio: -1204.9962602842184
Free cash flow (dilution-adjusted): -1136501.4598540145
Buyback yield (%): 0
Retained earnings: -13796975.18248175
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.24373604831717
Rule of 40 score: 0
Financial ratios for ECOR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.74
Shares outstanding: 8295707
Market cap (USD): 72504479.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECOR — annual report dated 2022-12-31
Total revenue: 8592000
Gross profit: 6976000
Operating income: -22874000
Net income: -22162000
Capital expenditures: 0
Operating cash flow: -16645000
Depreciation & amortization: 596000
Net tangible assets: 17086000
Owner earnings: -21566000
Return on net tangible assets (%): -126.22029731944282
Buffett classification: The Gruesome
Stock price: 3.86
Shares outstanding: 8295707
Book value: 17086000
P/B ratio: 1.8741325658433803
Market cap (USD): 32021429.02
Debt to equity: 0.04091068711225565
Current ratio: 3.0053938963804114
Quick ratio: 2.7249112845990062
COGS to revenue (%): 18.808193668528865
R&D to revenue (%): 64.24581005586593
SG&A to revenue (%): 283.1703910614525
Free cash flow (dilution-adjusted): -19327000
Buyback yield (%): 0
Retained earnings: -146370000
Inventory turnover: 0.8178137651821862
Receivables turnover: 21.42643391521197
Capitalized R&D asset: 5520000
ROCI (R&D-adjusted, %): -82.6223580560458
FCF margin (%): -224.94180633147113
Rule of 40 score: -224.94180633147113
Financial ratios for ECOR — annual report dated 2023-12-31
Total revenue: 16030000
Gross profit: 13226000
Operating income: -19269000
Net income: -18834000
Capital expenditures: 206000
Operating cash flow: -14668000
Depreciation & amortization: 1025000
Net tangible assets: 7442000
Owner earnings: -18015000
Return on net tangible assets (%): -242.07202364955657
Buffett classification: The Gruesome
Stock price: 5.95
Shares outstanding: 8295707
Book value: 7442000
P/B ratio: 6.632552626981994
Market cap (USD): 49359456.65
Debt to equity: 0.08411717280300994
Current ratio: 1.7596946940785425
Quick ratio: 1.4937830850670935
COGS to revenue (%): 17.49220212102308
R&D to revenue (%): 33.194011228945726
SG&A to revenue (%): 169.51965065502185
Free cash flow (dilution-adjusted): -16572000
Buyback yield (%): 0
Retained earnings: -165204000
Inventory turnover: 1.298148148148148
Receivables turnover: 22.357043235704325
Capitalized R&D asset: 9019400
ROCI (R&D-adjusted, %): -103.31364520582329
Rosenberg metric: 1.1322463768115942
FCF margin (%): -103.38116032439177
Revenue growth (%): 86.56890130353817
Rule of 40 score: -16.812259020853602
Financial ratios for ECOR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.22
Shares outstanding: 8295707
Market cap (USD): 59895004.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECOR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.21
Shares outstanding: 8295707
Market cap (USD): 134473410.47
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECOR — annual report dated 2024-12-31
Total revenue: 25182000
Gross profit: 21397000
Operating income: -12162000
Net income: -11886000
Capital expenditures: 0
Operating cash flow: -6948000
Depreciation & amortization: 1258000
Net tangible assets: 7544000
Owner earnings: -10628000
Return on net tangible assets (%): -140.88016967126194
Buffett classification: The Gruesome
Stock price: 16.21
Shares outstanding: 8295707
Book value: 7544000
P/B ratio: 17.825213476935314
Market cap (USD): 134473410.47
Debt to equity: 0.5482502651113468
Current ratio: 1.7810314685314685
Quick ratio: 1.597902097902098
Interest coverage ratio: -31.26478149100257
COGS to revenue (%): 15.030577396553094
R&D to revenue (%): 9.371773489000079
SG&A to revenue (%): 123.89405130648876
Free cash flow (dilution-adjusted): -8818000
Buyback yield (%): 0
Retained earnings: -177090000
Inventory turnover: 2.2583532219570404
Receivables turnover: 18.421360643745427
Capitalized R&D asset: 7746670
ROCI (R&D-adjusted, %): -74.49165611978668
Rosenberg metric: 1.5356136064649502
FCF margin (%): -35.01707568898419
Revenue growth (%): 57.09295071740487
Rule of 40 score: 22.075875028420676
Financial ratios for ECOR — quarterly report dated 2025-03-31
Total revenue: 6719000
Gross profit: 5706000
Operating income: -3822000
Net income: -3855000
Capital expenditures: 37000
Operating cash flow: -4355000
Depreciation & amortization: 194000
Net tangible assets: 4365000
Owner earnings: -3698000
Return on net tangible assets (%): -84.71935853379152
Buffett classification: The Gruesome
Stock price: 6.69
Shares outstanding: 8295707
Book value: 4365000
P/B ratio: 12.71438254982818
Market cap (USD): 55498279.830000006
Debt to equity: 0.9585337915234823
Current ratio: 1.5239307535641549
Quick ratio: 1.303335030549898
Interest coverage ratio: -764.4
COGS to revenue (%): 15.076648310760529
R&D to revenue (%): 9.554993302574788
SG&A to revenue (%): 132.2518231879744
Free cash flow (dilution-adjusted): -4932000
Buyback yield (%): 0
Retained earnings: -180945000
Inventory turnover: 0.584535487593768
Receivables turnover: 4.605209047292666
Capitalized R&D asset: 642000
ROCI (R&D-adjusted, %): -38.45020958423021
FCF margin (%): -73.40378032445304
Rule of 40 score: -73.40378032445304
Financial ratios for ECOR — quarterly report dated 2025-06-30
Total revenue: 7381000
Gross profit: 6442000
Operating income: -3506000
Net income: -3671000
Capital expenditures: 25000
Operating cash flow: -623000
Depreciation & amortization: 159000
Net tangible assets: 1113000
Owner earnings: -3537000
Return on net tangible assets (%): -317.78975741239896
Buffett classification: The Gruesome
Stock price: 5.28
Shares outstanding: 8295707
Book value: 1113000
P/B ratio: 39.35429735849057
Market cap (USD): 43801332.96
Debt to equity: 3.803234501347709
Current ratio: 1.0976294447910169
Quick ratio: 0.9492618007901851
COGS to revenue (%): 12.72185340739737
R&D to revenue (%): 6.923181140766833
SG&A to revenue (%): 127.855304159328
Free cash flow (dilution-adjusted): -1153000
Buyback yield (%): 0
Retained earnings: -184616000
Inventory turnover: 0.6580238262088297
Receivables turnover: 9.078720787207873
Capitalized R&D asset: 941140
ROCI (R&D-adjusted, %): -57.45074638368576
Rosenberg metric: 1.146417445482866
FCF margin (%): -15.62118954071264
Revenue growth (%): 9.852656645334127
Rule of 40 score: -5.768532895378513
Financial ratios for ECOR — quarterly report dated 2025-09-30
Total revenue: 8689000
Gross profit: 7470000
Operating income: -2884000
Net income: -3405000
Capital expenditures: 4000
Operating cash flow: -1669000
Depreciation & amortization: 153000
Net tangible assets: -1073000
Owner earnings: -3256000
Buffett classification: The Gruesome
Stock price: 4.95
Shares outstanding: 8295707
Book value: -1073000
Market cap (USD): 41063749.65
Debt to equity: -10.073625349487418
Current ratio: 1.4287949921752738
Quick ratio: 1.3291326908821348
Interest coverage ratio: -13.865384615384615
COGS to revenue (%): 14.02923236275751
R&D to revenue (%): 7.618828403728853
SG&A to revenue (%): 111.54333064794568
Free cash flow (dilution-adjusted): -2088000
Buyback yield (%): 0
Retained earnings: -188021000
Inventory turnover: 1.0074380165289256
Receivables turnover: 5.878890392422192
Capitalized R&D asset: 1216230
ROCI (R&D-adjusted, %): -26.95659387655272
Rosenberg metric: 2.01174168297456
FCF margin (%): -24.030383243181035
Revenue growth (%): 17.721175992412952
Rule of 40 score: -6.3092072507680825
Financial ratios for ECOR — quarterly report dated 2025-12-31
Total revenue: 9243000
Gross profit: 8170000
Operating income: -2941000
Net income: -3035000
Capital expenditures: 0
Operating cash flow: -1540000
Depreciation & amortization: 1169000
Net tangible assets: -1709000
Owner earnings: -1866000
Buffett classification: The Gruesome
Stock price: 4.49
Shares outstanding: 8295707
Book value: -1709000
Market cap (USD): 37247724.43
Debt to equity: -5.5020479812756
Current ratio: 1.3805075784279168
Quick ratio: 1.2367818117729996
Interest coverage ratio: -9.07716049382716
COGS to revenue (%): 11.608785026506546
R&D to revenue (%): 9.953478307908687
SG&A to revenue (%): 110.25641025641026
Free cash flow (dilution-adjusted): -2010000
Buyback yield (%): 0
Retained earnings: -191056000
Inventory turnover: 0.6578786020846107
Receivables turnover: 9
Capitalized R&D asset: 1532170
ROCI (R&D-adjusted, %): -30.71533669183471
Rosenberg metric: 1.0574018126888218
FCF margin (%): -21.746186303148328
Revenue growth (%): 6.375877546322937
Rule of 40 score: -15.370308756825391
Financial ratios for ECOR — annual report dated 2025-12-31
Total revenue: 32032000
Gross profit: 27788000
Operating income: -13153000
Net income: -13966000
Capital expenditures: 66000
Operating cash flow: -8187000
Depreciation & amortization: 1675000
Net tangible assets: -1709000
Owner earnings: -12357000
Buffett classification: The Gruesome
Stock price: 4.49
Shares outstanding: 8295707
Book value: -1709000
Market cap (USD): 37247724.43
Debt to equity: -5.5020479812756
Current ratio: 1.3805075784279168
Quick ratio: 1.2367818117729996
Interest coverage ratio: -22.29322033898305
COGS to revenue (%): 13.249250749250749
R&D to revenue (%): 8.538336663336663
SG&A to revenue (%): 119.27447552447552
Free cash flow (dilution-adjusted): -10183000
Buyback yield (%): 0
Retained earnings: -191056000
Inventory turnover: 2.6020846106683018
Receivables turnover: 31.189873417721518
Capitalized R&D asset: 6072130
ROCI (R&D-adjusted, %): -103.72537642454371
Rosenberg metric: 2.7080508474576273
FCF margin (%): -31.790084915084915
Revenue growth (%): 27.201969660868876
Rule of 40 score: -4.588115254216039
Financial ratios for ENVB — annual report dated 2021-12-31
Gross profit: 0
Capital expenditures: 189719
Buffett classification: The Gruesome
Stock price: 8370
Shares outstanding: 4028477
Market cap (USD): 33718352490
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENVB — annual report dated 2022-12-31
Total revenue: 0
Operating income: -19961444
Net income: -18471333
Capital expenditures: 584165
Operating cash flow: -17146723
Depreciation & amortization: 435201
Net tangible assets: 14292238
Owner earnings: -18620297
Return on net tangible assets (%): -130.28258415511974
Buffett classification: The Gruesome
Stock price: 374.4
Shares outstanding: 4028477
Book value: 15556952
P/B ratio: 96.9509829946123
Market cap (USD): 1508261788.8
Debt to equity: 0.004102346012252272
Current ratio: 4.612628013252341
Quick ratio: 4.612628013252341
Interest coverage ratio: -3802.9041722232805
Free cash flow (dilution-adjusted): -20351559
Buyback yield (%): 0
Retained earnings: -79207786
Capitalized R&D asset: 8027773
ROCI (R&D-adjusted, %): -61.945158713249086
Rule of 40 score: 0
Financial ratios for ENVB — annual report dated 2023-12-31
Total revenue: 0
Operating income: -18296675
Net income: -17291732
Capital expenditures: 11667
Operating cash flow: -14094411
Depreciation & amortization: 408030
Net tangible assets: 1745404
Owner earnings: -16895369
Return on net tangible assets (%): -967.9918803898696
Buffett classification: The Gruesome
Stock price: 234
Shares outstanding: 4028477
Book value: 1956336
P/B ratio: 481.8515929778934
Market cap (USD): 942663618
Debt to equity: 0
Current ratio: 1.528280301633793
Quick ratio: 1.528280301633793
Free cash flow (dilution-adjusted): -16249751
Buyback yield (%): 0.11160471030292803
Retained earnings: -96499518
Receivables turnover: 0
Capitalized R&D asset: 12631044.91
ROCI (R&D-adjusted, %): -110.62740757164016
Rule of 40 score: 0
Financial ratios for ENVB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.32
Shares outstanding: 4028477
Market cap (USD): 343709657.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENVB — annual report dated 2024-12-31
Total revenue: 0
Operating income: -9632266
Net income: -9574987
Capital expenditures: 0
Operating cash flow: -7726139
Depreciation & amortization: 337489
Net tangible assets: 1550625
Owner earnings: -9237498
Return on net tangible assets (%): -595.727400241838
Buffett classification: The Gruesome
Stock price: 64.44
Shares outstanding: 4028477
Book value: 1592807
P/B ratio: 162.97960636787758
Market cap (USD): 259595057.88
Debt to equity: 0
Current ratio: 1.8356165119188903
Quick ratio: 1.8356165119188903
Free cash flow (dilution-adjusted): -9288531
Buyback yield (%): 0
Retained earnings: -106074505
Capitalized R&D asset: 10349569.88
ROCI (R&D-adjusted, %): -107.44500972406088
Rule of 40 score: 0
Financial ratios for ENVB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 64.44
Shares outstanding: 4028477
Market cap (USD): 259595057.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENVB — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -2187533
Net income: -2184966
Capital expenditures: 0
Operating cash flow: -2391582
Depreciation & amortization: 81024
Net tangible assets: 3917713
Owner earnings: -2103942
Return on net tangible assets (%): -53.703321299952286
Buffett classification: The Gruesome
Stock price: 16.68
Shares outstanding: 4028477
Book value: 3917713
P/B ratio: 17.15158725511542
Market cap (USD): 67194996.36
Debt to equity: 0
Current ratio: 4.08207996244531
Quick ratio: 4.08207996244531
Free cash flow (dilution-adjusted): -2585430
Buyback yield (%): 0
Retained earnings: -108259471
Capitalized R&D asset: 746371
ROCI (R&D-adjusted, %): -36.233316838490325
Rule of 40 score: 0